Published in Nature on February 26, 2015
Contact-Dependent Growth Inhibition (CDI) and CdiB/CdiA Two-Partner Secretion Proteins. J Mol Biol (2015) 0.87
How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol (2016) 0.80
Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients (2016) 0.79
Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology (2016) 0.78
Dysbiotic drift: mental health, environmental grey space, and microbiota. J Physiol Anthropol (2015) 0.78
Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access (2016) 0.76
Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. J Int Soc Sports Nutr (2016) 0.76
Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier. PLoS One (2015) 0.76
The microbiome of the built environment and mental health. Microbiome (2015) 0.76
Gut Microbiota-brain Axis. Chin Med J (Engl) (2016) 0.75
Probiotics as a Potential Alternative for Relieving Peripheral Neuropathies: a Case for Guillain-Barré Syndrome. Front Microbiol (2016) 0.75
The Microbiome and Mental Health: Looking Back, Moving Forward with Lessons from Allergic Diseases. Clin Psychopharmacol Neurosci (2016) 0.75
Gene environment interaction in periphery and brain converge to modulate behavioral outcomes: Insights from the SP1 transient early in life interference rat model. World J Psychiatry (2016) 0.75
Human Microbiome Engineering: The Future and Beyond. J Clin Diagn Res (2015) 0.75
The microbiome as a novel paradigm in studying stress and mental health. Am Psychol (2017) 0.75
The psychosocial burden of childhood overweight and obesity: evidence for persisting difficulties in boys and girls. Eur J Pediatr (2017) 0.75
Anticancer effects of the microbiome and its products. Nat Rev Microbiol (2017) 0.75
Biodiversity. As isolation ends, Myanmar faces new ecological risks. Science (2012) 1.88
Regulators weigh risks of consumer genetic tests. Nat Biotechnol (2008) 1.84
RNAi momentum fizzles as pharma shifts priorities. Nat Biotechnol (2011) 1.46
20 years of Nature Biotechnology biomedical research. Nat Biotechnol (2016) 1.42
Gintuit cell therapy approval signals shift at US regulator. Nat Biotechnol (2012) 0.88
Lapatinib study supports cancer stem cell hypothesis, encourages industry research. J Natl Cancer Inst (2008) 0.87
FDA approves first cell therapy for wrinkle-free visage. Nat Biotechnol (2011) 0.86
Larger companies dominate cancer companion diagnostic approvals. Nat Biotechnol (2011) 0.79
Vaccines for pandemics. Nat Biotechnol (2013) 0.78
Bioelectronics: The bionic material. Nature (2012) 0.77
The Gompertzian view: Norton honored for role in establishing cancer treatment approach. J Natl Cancer Inst (2004) 0.77
The Kanzius machine: a new cancer treatment idea from an unexpected source. J Natl Cancer Inst (2008) 0.77
Yuan Chang and Patrick Moore: teaming up to hunt down cancer-causing viruses. J Natl Cancer Inst (2008) 0.76
Cancer stem cells in the crosshairs. Cancer Discov (2012) 0.76
The startup bugs. Nat Biotechnol (2013) 0.76
Living in a microbial world. Nat Biotechnol (2017) 0.76
Mammaprint Reveals Who Can Skip Chemotherapy for Breast Cancer. J Natl Cancer Inst (2016) 0.76
Pancreatic islets find a new transplant home in the omentum. Nat Biotechnol (2017) 0.75
Erratum: 20 years of Nature Biotechnology biomedical research. Nat Biotechnol (2016) 0.75
Immunology: Another shot at cancer. Nature (2015) 0.75
Immunotherapy: Controlled attack. Nature (2016) 0.75
Biotechs target stagnant baldness market. Nat Biotechnol (2016) 0.75
20 years of Nature Biotechnology bioengineering research. Nat Biotechnol (2016) 0.75
Sunlight on mirrors. Environ Sci Technol (2008) 0.75
A Myriad of questions. Cancer Discov (2012) 0.75
Breast cancer screening goes personalized. Cancer Discov (2012) 0.75
The Fog of Agent Orange. Sci Am (2016) 0.75
Psychiatric research. Severe autism, often slighted, now targeted for study. Science (2013) 0.75
Psychiatric research. Putting the brakes on psychosis. Science (2007) 0.75
Biology: A degenerative affliction. Nature (2016) 0.75
When Medical Tests Mislead. Sci Am (2016) 0.75
Biotech firms look for virtual success. Cancer Discov (2011) 0.75
Children with cancer get more access to experimental drugs. Science (2017) 0.75
Experts worry about chilling effect of federal regulations on treating pain. J Natl Cancer Inst (2005) 0.75
Salmon as transport vectors for mercury. Environ Sci Technol (2010) 0.75
Marine conservation. As threats to corals grow, hints of resilience emerge. Science (2013) 0.75
Pediatric Predicament. Sci Am (2017) 0.75
Without more federal support, success of U.S. stem cell research questioned. J Natl Cancer Inst (2005) 0.75
Stepping into the sunshine. Nat Biotechnol (2014) 0.75
Debate re-ignites on contribution of public research to drug development. Nat Biotechnol (2011) 0.75
Neither Here nor There. Sci Am (2016) 0.75
Don't Drink the Water. Sci Am (2017) 0.75
How PCBs are like grasshoppers. Environ Sci Technol (2010) 0.75
Energy. Despite data gaps, U.S. moves closer to drilling in Arctic Ocean. Science (2011) 0.75
First deuterated drug approved. Nat Biotechnol (2017) 0.75
PARP inhibitors refocus for rebound. Cancer Discov (2012) 0.75